BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16096899)

  • 1. Antidiabetic drug utilization in hungary.
    Hankó B; Tukarcs E; Kumli P; Vincze Z
    Pharm World Sci; 2005 Jun; 27(3):263-5. PubMed ID: 16096899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in antidiabetic drug utilisation between three different health systems in the same national region.
    Benítez J; Puerto AM; Díaz JA
    Eur J Clin Pharmacol; 1992; 42(2):151-4. PubMed ID: 1618245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practice of antidiabetic therapy in Hungary].
    Hankó BZ; Reszegi CA; Kumli P; Vincze Z
    Acta Pharm Hung; 2005; 75(2):77-86. PubMed ID: 16318232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug consumption in diabetes mellitus (III). Trends of hypoglycemic agents use and consumption in Tarragona, Catalonia, and Spain (1988- 1991). Group for the Study of Diabetes in Tarragona].
    Costa B; Hernández JM
    Med Clin (Barc); 1993 Apr; 100(15):571-5. PubMed ID: 8497145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and international comparison in utilization of antidiabetic drugs.
    Stanulović M; Jakovljević V; Kovac T; Lepsanović L; Ducić M
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):254-6. PubMed ID: 3525425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperglycaemic agents. Drug interactions of clinical importance.
    Scheen AJ; Lefèbvre PJ
    Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trends in antidiabetic treatment prescribed for patients with type 2 diabetes in Hungary between 2001 and 2014 - results from the database analysis of the National Health Insurance Fund].
    Jermendy G; Kiss Z; Rokszin G; Abonyi-Tóth Z; Wittmann I; Kempler P
    Orv Hetil; 2017 May; 158(20):770-778. PubMed ID: 28502212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of oral antihyperglycemic drugs over a 7-year period (1998-2004) in a Hungarian population and adherence to drug therapy.
    Doró P; Benko R; Kosik E; Matuz M; Tóth K; Soós G
    Eur J Clin Pharmacol; 2005 Dec; 61(12):893-7. PubMed ID: 16328320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug sales data and prevalence of diabetes in France.
    Fontbonne A; Papoz L; Eschwege E
    Rev Epidemiol Sante Publique; 1986; 34(2):100-5. PubMed ID: 3738066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and regional differences in antidiabetic medication use: a nationwide retrospective observational study.
    Csatordai M; Benkő R; Matuz M; Engi Z; Csupor D; Lengyel C; Doró P
    Diabetol Metab Syndr; 2024 Apr; 16(1):88. PubMed ID: 38658983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes therapy using oral antidiabetics].
    Hasslacher C; Wahl P
    Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long term efficacy and tolerance of antidiabetic treatments. New data].
    Mirouze J
    Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevalence and consumption of medication in diabetes mellitus in Madrid (1996-2002)].
    Arrieta FJ; Calvo MJ; Peréz A; Saavedra P; Cordobés FJ; Cabral R; Arrieta JJ; Rovira A
    Rev Clin Esp; 2006 Mar; 206(3):117-21. PubMed ID: 16597376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trends of antidiabetic drug prescriptions in Andalucia (1986-1994)].
    Olveira G; Soriguer F; Vázquez F; González-Romero S; Ruiz de Adana S; Aguilar M
    Aten Primaria; 1999; 24(3):145-51. PubMed ID: 10444868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of glucose-lowering drugs in Hungary between 2008 and 2017: the increasing use of novel glucose-lowering drug groups.
    Csatordai M; Benkő R; Matuz M; Bor A; Lengyel C; Doró P
    Diabet Med; 2019 Dec; 36(12):1612-1620. PubMed ID: 31456231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the indication and practical use of oral antidiabetics].
    Fankhauser S
    Schweiz Med Wochenschr; 1972 Jun; 102(24):856-62. PubMed ID: 5033624
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.